<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v9i7.11427</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Difficulties and Countermeasures of Monitoring Adverse Drug Reactions in Primary Medical Institutions</title><url>https://artdesignp.com/journal/JCNR/9/7/10.26689/jcnr.v9i7.11427</url><author>DuanYanpeng</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>9</volume><issue>7</issue><history><date date-type="pub"><published-time>2025-08-04</published-time></date></history><abstract>Monitoring adverse drug reactions (ADRs) in primary medical institutions is crucial to ensuring medication safety. Currently, this work faces difficulties such as insufficient professional ability of staff, imperfect monitoring systems, and low patient awareness. It is necessary to improve the level of ADR monitoring at the grassroots level and ensure the safety and effectiveness of medication through countermeasures such as strengthening personnel training, optimizing monitoring processes, and raising public awareness.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Liu A, Li X, Ding S, et al., 2021, Analysis of Adverse Drug Reaction Reports From Primary Medical Institutions in Dongguan City From 2015 to 2019. Strait Pharmaceutical Journal, 33(11): 201–203.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Diao K, Lv H, 2021, Problems and Countermeasures of Adverse Drug Reaction Monitoring in Primary Medical Institutions. Popular Standardization, (13): 204–206.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Lin Q, Huang M, Chen R, 2021, Discussion on the Role of Medical Institutions in Adverse Drug Reaction Monitoring and Management. Chinese Medical Management Science, 11(01): 87–90.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Qi J, Yao X, Bai Y, 2020, Analysis of Influencing Factors Restricting Adverse Drug Reaction Monitoring in Medical Institutions and Discussion on Countermeasures. Electronic Journal of Clinical Medical Literature, 7(20): 176–182.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Li H, Du J, Zhang G, et al., 2021, Analysis of Adverse Drug Reactions in a Primary Medical Institution in a Remote and Poverty-Stricken Area Over Five Years. Chinese Community Doctors, 37(06): 10–11.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
